(Press-News.org) The earliest days after fertilization, once a sperm cell meets an egg, are shrouded in scientific mystery.
The process of how a humble single cell becomes an organism fascinates scientists across disciplines. For some animals, the entire process of cellular multiplication, generation of specialized cells, and their organization into an ordered multicellular embryo takes place in the protective environment of the uterus, making direct observation and studies challenging. This makes it difficult for scientists to understand what can go wrong during that process, and how specific risk factors and the surrounding environment may prevent embryo formation.
Scientists at UC Santa Cruz were able to engineer cellular models of embryos without ever experimenting with any actual embryos, allowing them to mimic the first few days after two sexually reproductive cells meet. They use CRISPR-based engineering methods to prompt stem cells to organize into “programmable” embryo-like structures, also known as embryoids, which can be used to study the role of certain genes in early development. These structures are not actual embryos but assemblies of lab-grown cells that self-organize in ways that mimic some aspects of early developmental stages. Their results are published in the leading stem cell journal Cell Stem Cell.
“We as scientists are interested in recreating and repurposing natural phenomena, such as formation of an embryo, in the dish to enable studies that are otherwise challenging to do with natural systems,” said Ali Shariati, assistant professor of biomolecular engineering and the study’s senior author. “We want to know how cells organize themselves into an embryo-like model, and what could go wrong when there are pathological conditions that prevent an animal from successfully developing.”
Cell co-development
Shariati is an expert in stem cell engineering, a field that uses stem cells — unspecialized cells that can form any type of cell such as gut or brain cells — to study and solve biological and health problems.
This project, led by UCSC postdoctoral scholar Gerrald Lodewijk and biomolecular engineering alumna and current Caltech graduate student Sayaka Kozuki, used mouse stem cells that are commonly grown in the lab to guide them to form basic building blocks of the embryo.
The team used a version of CRISPR technology known as an epigenome editor, which does not cut DNA but instead modifies how it is expressed. They targeted regions of the genome known to be involved in the development of an early embryo. This allowed them to control which genes were activated, and induce the creation of main types of cells needed for early development.
“We use the stem cells, which are like a blank canvas, and use them to induce different cell types using our CRISPR tools,” Lodewijik said.
This method had the advantage of allowing different cell types to “co-develop,” which more closely resembles the natural embryo formation than the chemical approaches other scientists have used to develop different cell types.
“These cells co-develop together, just like they would in an actual embryo, and establish that history of being neighbors,” Shariati said. “We do not change their genome or expose them to specific signaling molecules, but rather activate the existing genes.”
The team found that 80% of the stem cells organize themselves into a structure that mimics the most basic form of an embryo after a few days, and most undergo gene activation that reflects the development process that occurs in living organisms.
“The similarity is remarkable in the way the cells organize themselves, as well as the molecular composition,” Shariati said. “[The cells require] very little input from us — it’s as if the cells already know what to do, and we just give them a little bit of guidance.”
The researchers observed that the cells showed a collective behavior in moving and organizing together.
“Some of them start doing this rotational migration, almost like the collective behavior of birds or other species,” Shariati said. “Through this collective behavior and migration they can form these fascinating embryonic patterns.”
“Programmable” models
Having an accurate baseline model that reflects a living organisms’ early embryo could allow scientists to better study and learn how to treat developmental disorders or mutations.
“These models have a more complete representation of what’s going on in early stages of development, and can capture the background,” Lodewijik said.
The CRISPR programming not only allows the scientists to activate the genes at the beginning of the experimentation process, but also enables them to activate or modify genes important for other parts of development. This allows the embryo models to be “programmable,” meaning they can be relatively easily influenced with a high level of control to target and test the impact of multiple genes as the embryo model develops, illuminating which have deleterious effects when turned on or off.
As an example, the researchers demonstrated how certain tissues form or are hindered during early development, but their methods could be used to study a wide range of genes and their cascading effects on the cell types.
“I think this is the pioneering work of this study — the programmability and that we don’t rely on extrinsic factors to do this, but rather have a lot of control inside the cell,” Shariati said.
The researchers are interested in how this approach might be used to study other species, allowing for a look into their embryo formation without ever using their actual embryos.
This research could allow for the study of the bottlenecks that lead reproduction to fail in early stages. Among mammals, humans have more reproduction challenges in that human embryos often fail to implant or establish the correct early organizational form. Understanding why this is the case could help make progress toward improving human fertility.
END
Scientists use cellular programming to mimic first days of embryonic development
2025-03-20
ELSE PRESS RELEASES FROM THIS DATE:
Potential targeted therapy for pediatric brain cancer identified by Dana-Farber team
2025-03-20
Boston – An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a first-ever clinical test of the targeted therapy avapritinib in pediatric and young patients with a form of high-grade glioma. They found that the drug, already FDA-approved for certain adult cancers, was generally safe and resulted in tumor reduction visible on brain scans, as well as clinical improvement, in 3 out of 7 patients.
The study was published in Cancer Cell.
Pediatric-type high-grade gliomas are currently incurable brain tumors with median survival times less than 18 months after initial diagnosis.
Avapritinib ...
Self-assembled vesicles containing podophyllotoxin covalently modified with polyoxometalates for antitumor therapy
2025-03-20
POMs are a class of inorganic metal-oxygen cluster compounds with broad-spectrum antitumor potential. However, their strong hydrophilicity and poor lipophilicity result in insufficient cell membrane permeability, and high doses are required to achieve therapeutic effects, which severely limits their clinical application. To address this challenge, the research team proposes a covalent modification strategy: the construction of an amphipathic drug molecule PPT-POM-PPT by linking the hydrophobic anti-tumor drug Podophyllotoxin (PPT) with hydrophilic POMs. This molecule ...
Circadian rhythms in tumor regulation: Impacts on tumor progression and the immune microenvironment
2025-03-20
Circadian rhythms are endogenous time-keeping mechanisms that regulate physiological processes in response to external light-dark cycles. These rhythms are orchestrated by the suprachiasmatic nucleus (SCN) in the hypothalamus and involve a network of genes, including CLOCK and BMAL1, that influence metabolism, immune responses, and cell proliferation. Recent research has highlighted the crucial role of circadian rhythms in tumor biology, demonstrating that their dysregulation contributes to tumorigenesis, progression, and metastasis. Additionally, circadian rhythms influence the tumor immune microenvironment and the ...
The emerging role of flavonoids in the treatment of type 2 diabetes mellitus: regulating the enteroendocrine system
2025-03-20
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily characterized by insulin resistance, β-cell dysfunction, and impaired glucose homeostasis. Emerging research suggests that flavonoids, a diverse group of plant-derived polyphenols, may offer therapeutic potential in managing T2DM. These compounds exert antidiabetic effects through multiple mechanisms, including improving insulin sensitivity, enhancing β-cell function, modulating ...
Improving patient experience for the millions who visit an ED annually
2025-03-20
INDIANAPOLIS -- A large scale study by researchers from the Regenstrief Institute and the Indiana University School of Medicine has found that patient pain upon arrival to the Emergency Department (ED) as well as the use of hallway beds and radiology studies in the ED are associated with patient experience, although not in the same ways.
The study’s tens of thousands of observations including clinical and operational data revealed that regardless of how promptly or successfully pain was treated in the ED, the amount of pain the patient was in when they arrived was associated with patient experience ...
Recycled cements drive down emissions without slacking on strength
2025-03-20
Giving a second life to construction materials after demolition, engineers at the University of São Paulo and Princeton have developed an approach for recycling cement waste into a sustainable, low-carbon alternative that is comparable in performance to the industry standard.
In addition to lowering the carbon intensity of the cement and concrete industry, the process could enable new uses for construction and demolition waste, of which concrete is a significant component. In 2018 in the United States, the total ...
Beyond the cure: Navigating hepatocellular risk and surveillance after hepatitis C eradication in the direct-acting antiviral era
2025-03-20
Hepatitis C virus (HCV) infection remains a major global health burden, affecting millions worldwide and contributing significantly to hepatocellular carcinoma (HCC) development. The introduction of direct-acting antivirals (DAAs) has revolutionized HCV treatment, achieving high rates of sustained virologic response (SVR) and reducing HCV-associated morbidity and mortality. Despite these advancements, the risk of HCC persists in certain populations, particularly those with pre-treatment cirrhosis or advanced fibrosis (F3). This review examines the ...
Lupus Research Alliance grants inaugural awards to 11 researchers focused on engineered cell therapies for. Lupus
2025-03-20
The Lupus Research Alliance (LRA) is proud to announce the inaugural recipients of the new Targeted Research Program on Engineered Cell Therapies for Lupus (TRP-ECT) to support the development and mechanistic understanding of safe and accessible next-generation engineered cell therapies for people with lupus. Engineered cell therapies, such as CD19-targeted chimeric antigen receptor (CAR) T cells, involve reengineering a patient’s own T cells to recognize and attack cells that cause disease.
The LRA established this program to build upon the promise already shown for engineered cell therapies in treating and potentially curing lupus, including ...
Researchers discover Achilles heel of Lyme disease pathogen
2025-03-20
Washington, D.C.—Researchers have discovered that an enzyme can serve as an ideal target for developing new therapeutics against Lyme disease, and most likely other tick-borne diseases as well. The finding was reported in mBio, a journal of the American Society for Microbiology.
Lyme disease is the most commonly reported tick-borne illness in the United States and Europe. Its causative pathogen, Borrelia burgdorferi, has evolved unique metabolic pathways to cope with its enzootic life cycle, ...
Oxygen discovered in most distant known galaxy
2025-03-20
Two different teams of astronomers have detected oxygen in the most distant known galaxy, JADES-GS-z14-0. The discovery, reported in two separate studies, was made possible thanks to the Atacama Large Millimeter/submillimeter Array (ALMA), in which the European Southern Observatory (ESO) is a partner. This record-breaking detection is making astronomers rethink how quickly galaxies formed in the early Universe.
Discovered last year, JADES-GS-z14-0 is the most distant confirmed galaxy ever found: it is so far away, its light took 13.4 billion years to reach us, meaning we see it as it was when the Universe was less than 300 million years old, about 2% of its present age. ...